• 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Analysts

    المصدر: Buzz FX / 26 يناير 2025 04:51:18   America/New_York


    4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat January 26, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics, Inc.
    Read more...
شارك على،